The Only Complete Online Marketing Firm
Tuesday, November 24, 2015
Dual HER2 Inhibition Flops as Adjuvant Breast Ca Tx (CME/CE)
(MedPage Today) -- Lapatinib-trastuzumab no better than trastuzumab alone
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment